Get in touch to learn more about medical cannabis, share your thoughts & be in-the-know for exclusive offers, products, & events.
Monday to Friday
8 AM - 7 PM EST
Saturday & Sunday
9 AM - 5 PM EST
Perla is an Indica-dominant CBD strain that has demonstrated a consistently robust cannabinoid profile through numerous laboratory analyses. As our first in-house strain, Perla exhibits well-balanced effects in both body and mind.
Fluent products are not intended to diagnose, treat, cure or prevent any disease and have not been evaluated by the Food and Drug Administration. Consult your physician or provider before starting or stopping any medical cannabis product.
Drops
1500 mg in 30 mL (~50 mg CBD/mL; ~0.5 mg THC/mL)
Tinctures are absorbed sublingually, so essential cannabinoids are absorbed directly into the bloodstream. Effects are delayed through the absorption process but are prolonged. The application is very discreet, with no odor.
Perla oil is to be administered orally. The starting dose is 2.5 mg twice daily (5 mg a day). Patients are recommended to initiate treatment on the evening of Day 1 with 2.5 mg. After 5-7 days, the dose can be gradually increased to 5 mg twice a day (10 mg a day).
Patients who are tolerating Perla at 5 mg twice daily and who may benefit from a dosage increase can be further titrated to a maximum recommended maintenance dosage of 10 mg twice daily (20 mg a day). This should be titrated over several weeks, as tolerated. Dosage should not be increased more frequently than every other day.
Perla is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Perla;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.
3000 mg in 30 mL (~100 mg CBD/mL; ~0.5 mg THC/mL)
Tinctures are absorbed sublingually, so essential cannabinoids are absorbed directly into the bloodstream. Effects are delayed through the absorption process but are prolonged. The application is very discreet, with no odor.
Perla oil is to be administered orally. The starting dose is 2.5 mg twice daily (5 mg a day). Patients are recommended to initiate treatment on the evening of Day 1 with 2.5 mg. After 5-7 days, the dose can be gradually increased to 5 mg twice a day (10 mg a day).
Patients who are tolerating Perla at 5 mg twice daily and who may benefit from a dosage increase can be further titrated to a maximum recommended maintenance dosage of 10 mg twice daily (20 mg a day). This should be titrated over several weeks, as tolerated. Dosage should not be increased more frequently than every other day.
Perla is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Perla;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.
